US · NMTC
NeuroOne Medical Technologies Corporation
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Eden Prairie, MN 55344
- Website
- n1mtc.com
Price · as of 2025-09-30
$4.35
Market cap 33.87M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $60.35 | +1,287.36% |
| Intrinsic Value(DCF) | $1,515.43 | +34,737.47% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $0.00 | $0.00 | |||
| 2012 | $0.00 | $0.59 | |||
| 2013 | $0.00 | $0.00 | |||
| 2014 | $0.00 | $0.61 | |||
| 2015 | $0.00 | $0.00 | |||
| 2016 | |||||
| 2017 | $12.30 | ||||
| 2018 | $17.67 | ||||
| 2019 | $8.94 | ||||
| 2020 | $3.70 | $18.20 | $0.00 | ||
| 2021 | $2.44 | $38.73 | $0.00 | $0.00 | $73.21 |
| 2022 | $2.82 | $28.28 | $0.59 | $0.00 | $0.00 |
| 2023 | $1.92 | $122.91 | $3,645.78 | $0.00 | $0.00 |
| 2024 | $0.59 | $35.21 | $11,884.59 | $0.00 | $0.00 |
| 2025 | $0.71 | $60.35 | $1,707,366.80 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates NeuroOne Medical Technologies Corporation's (NMTC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $60.35
- Current price
- $4.35
- AI upside
- +1,287.36%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1,515.43
+34,737.47% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NMTC | NeuroOne Medical Technolo… | $4.35 | 33.87M | +1,287% | +34,737% | — | — | -7.93 | 4.04 | 2.36 | -7.40 | — | 4.07 | 67.30% | -34.94% | -29.80% | -91.34% | -2161.45% | -44.63% | 0.04 | -12.65 | 4.44 | 3.40 | 2.09 | -8043.00% | 25035.00% | -7378.00% | -10.21% | -1.23 | -1492.81% | 0.00% | 0.00% | 18.29% | -5.27 | -7.63 | 1.84 | -4.87 |
| ATHE | Alterity Therapeutics Lim… | $3.44 | 58.29M | +500% | +3% | — | — | -6.79 | 1.95 | 15.18 | -2.87 | — | 1.95 | 97.66% | -267.96% | -223.35% | -43.23% | -905.76% | -37.23% | 0.00 | — | 12.98 | 12.62 | 2.26 | -6346.00% | 3532.00% | -920.00% | -13.87% | -3.24 | -711.67% | 0.00% | 0.00% | 24.86% | -2.88 | -3.67 | 7.73 | 6.97 |
| BDMD | Baird Medical Investment … | $2.98 | 109.44M | +1,873% | +2% | +34% | +311% | 8.01 | 2.55 | 2.73 | 7.35 | 41.06 | 2.55 | 88.16% | 41.35% | 33.62% | 33.41% | 26.96% | 18.71% | 0.53 | 26.55 | 1.77 | 1.43 | 1.11 | 1951.00% | 1774.00% | 15056.00% | -9.08% | -0.18 | -18.05% | 0.00% | 0.00% | 0.00% | 7.76 | -12.97 | 3.21 | 3.60 |
| CTSO | Cytosorbents Corporation | $0.75 | 47.26M | +3,558% | -47% | — | — | -2.65 | 4.95 | 1.54 | -5.17 | — | 7.47 | 70.59% | -47.16% | -58.21% | -120.52% | -49.92% | -41.18% | 2.42 | -12.00 | 2.20 | 1.08 | -1.55 | -4154.00% | 1451.00% | -3488.00% | -26.76% | -1.47 | -47.32% | 0.00% | 0.00% | 0.00% | -4.68 | -5.34 | 2.21 | -8.19 |
| ECOR | electroCore, Inc. | $7.58 | 60.61M | +1,415% | +10,410% | — | — | -8.88 | 13.99 | 4.19 | -8.96 | — | 13.99 | 84.97% | -48.30% | -47.20% | -158.63% | 945.74% | -65.00% | 0.55 | — | 1.78 | 1.46 | -0.06 | -5351.00% | 5709.00% | -5329.00% | -6.59% | -0.76 | 544.51% | 0.00% | 0.00% | 0.00% | -8.03 | -14.06 | 3.88 | -7.53 |
| HYPD | Hyperion DeFi, Inc. | $2.82 | 16.06M | +1,294% | +147,433% | — | — | -0.03 | -0.10 | 23.10 | -0.23 | -0.21 | -0.10 | -6749.50% | -85004.58% | -86888.57% | 2432.03% | -1558.51% | -307.07% | -0.86 | -19.62 | 0.17 | 0.13 | -0.20 | 1253.00% | 141402.00% | 890.00% | -2286.39% | -1.88 | -968.35% | 0.00% | 0.00% | 0.00% | -0.21 | -0.34 | 182.16 | -122.68 |
| RBOT | Vicarious Surgical Inc. | $2.04 | 13.19M | — | — | — | — | -0.87 | 1.17 | — | -0.32 | — | 1.17 | 0.00% | — | — | -87.40% | -511.76% | -67.41% | 0.30 | — | 6.74 | 6.40 | -0.07 | -2658.00% | — | -2163.00% | -91.59% | -6.52 | -385.51% | 0.00% | 0.00% | 0.00% | -0.29 | -0.39 | — | -4.95 |
| STRR | Star Equity Holdings, Inc… | $9.98 | 34.29M | +11,500% | +1,775,496% | — | +1,761% | -3.07 | 0.79 | 0.60 | -3.35 | -1.19 | 1.00 | 20.72% | -15.77% | -19.56% | -23.46% | -32.46% | -18.39% | 0.03 | — | 3.58 | 3.31 | 3.31 | 25766.00% | -6693.00% | -50185.00% | -25.05% | -0.46 | -31.00% | 6.36% | -19.50% | 7.23% | -1.92 | -2.01 | 0.30 | -8.72 |
| YI | 111, Inc. | $7.91 | 68.56M | +302% | -56% | — | — | -25.62 | -0.83 | 0.04 | 13.27 | — | -0.83 | 5.76% | 0.01% | -0.45% | 3.39% | -0.26% | -0.71% | -0.40 | 0.07 | 1.13 | 0.47 | -8.35 | -8386.00% | -366.00% | -15422.00% | 46.56% | 0.11 | -30.18% | 0.00% | 0.00% | 8.50% | 154.56 | 1.32 | 0.02 | 3.48 |
| ZYXI | Zynex, Inc. | $0.09 | 2.73M | +47,067% | +3,167% | +949% | +1,186% | 78.41 | 6.57 | 1.22 | 24.92 | — | 29.13 | 79.50% | 3.11% | 1.56% | 7.32% | 6.70% | 2.31% | 2.07 | 2.51 | 4.46 | 3.42 | 3.17 | -6667.00% | 436.00% | -2663.00% | 5.17% | 0.75 | 16.45% | 0.00% | 0.30% | 6.66% | 44.90 | 22.15 | 1.40 | 4.28 |
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
- CEO
- David A. Rosa
- Employees
- 17
- Beta
- 0.62
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1,515.43 ÷ $4.35) − 1 = +34,737.47% (DCF, example).